iCo Therapeutics reports topline primary endpoint data from phase II study of iCo-007 June 11, 2014 No Comments
FDA approves Omidria for use in cataract and intraocular lens replacement procedures June 3, 2014 No Comments
XOMA presents a novel anti-TGF-beta MAb for the treatment of proliferative vitreoretinopathy June 2, 2014 No Comments
RSS